Case study submitted as part of Lancet Commission call for case studies.
Team members
Elena Grossman, MPH, Sheetal Khedkar Rao, MD, Marie Heffernan, PhD, Erika Ninos, Monica Nakielski, Michelle…
Published date
•
by
Elena Grossman, MPH, Sheetal Khedkar Rao, MD, Marie Heffernan, PhD, Erika Ninos, Monica Nakielski, Michelle Hoersch
Case study submitted as part of Lancet Commission call for case studies.
Team members / location: Professor Mary Lynch/UK/Republic of Ireland/University of KwaZulu-Natal
Issue:The KwaZulu-Natal…
Case study submitted as part of Lancet Commission call for case studies.
Team members / location:Brian Gray/ Baltimore, Maryland, United States
Issue:MedStar Harbor Hospital (MHH) sits on…
In-hospital promotion of the oral route and IV to oral switch (IVOST) are key antimicrobial stewardship (AS) initiatives providing benefits for patients, staff and the environment, including reduced…
Published date
August 2024
•
by
Rodger R, Robertson A, Thompson E, Downie K, Thompson S, Ray G, Chisholm L, Hillson R
CASCADES (Creating a Sustainable Canadian Health System in a Climate Crisis) has published a series of implementation resources for sustainable pharmacy and prescribing practices. At present these…
This report from Healthcare Without Harm highlights successful initiatives across Europe where pharmacists are taking the lead in promoting responsible medicine use, reducing pharmaceutical waste, and…
I've created various resources to engage the public and the profession and help improve our well-being. This is the newest one and has references to previous resources.
The UK government green…
(from abstract)
This studymeasured the extent of active pharmaceutical ingredient (API) contamination in the English national parks by monitoring 54 APIs in 37 rivers across all national parks over…
Case study submitted as part of Lancet Commission call for case studies.
Team members / location: Marianne Dawson, Canada, British Columbia
Issue: To scale sustainable change and not add to the…
To scale and spread promotion of the oral route in antimicrobials with high oral bioavailability with the aim of reducing collective IV use by 20% by February 2023 at RAH.
Published date
June 2023
•
by
R Rodger, S Thompson, A Robertson, C Pender, G Ray, L Chisholm